  |
AsMA NewsNews of Corporate Members February 2010 Eagle Receives Contractor of the Year Award
Eagle Applied Sciences, LLC was awarded the 2009 Minority Contractor of the Year award from the San Antonio Business Opportunity Council on October 21 for Eagle’s ability to execute the U.S. Air Force School of Aerospace (USAFSAM) contract with excellence. On hand to receive the award was Dr. Guy Banta (AsMA Fellow), President and CEO of Eagle, since its inception, just a mere 3 years ago. Eagle is a Small Disadvantaged Business and is a wholly owned subsidiary of the Bristol Bay Native Corporation (BBNC), a dynamic Alaska Native Corporation (ANC), recognized for its excellence in program-project management, medical and applied sciences, medical informatics and biomedical R&D services. Dr. Karen Fox (AsMA Fellow) is the Medical Director for Eagle. Eagle employs over 60 personnel within USAFSAM and supports the two primary missions of USAFSAM, training and evaluating the health of the warfighter. Eagle’s physicians, curriculum specialists, foreign military medical education support specialists, audiovisual technicians, and medical simulation technicians are involved in the training of all AF flight surgeons, Residency of Aerospace Medicine, fellowship training in Hyperbaric Medicine and all AF bioenvironmental engineers and technicians, public health officers and technicians, and specialists in international health and aerospace physiology. Eagle’s physicians (ophthalmology, hyperbaric medicine, neurology, psychiatry and flight surgeons), optometrist, ophthalmic technicians, medical and dental assistants, medical records technicians, case managers, mental health specialists, psychologist, cardiopulmonary technicians and statisticians are intimately involved in the Aeromedical Consultation Services mission. They perform complicated medical assessments for rated staff providing recommendations as to their suitability to return or continue to perform aircrew duties. Their staff also performs initial AF flying physicals and FAA class 3 physicals on all AF ROTC cadet pilot candidates, as well as provides treatment with hyperbaric medicine for DoD eligible patients and develops and maintains the AF Waiver Guide. Eagle employees at USAFSAM included two other AsMA Fellows, Dr. Doug Ivan and Dr. Dan Van Syoc and an AsMA Associate Fellow, Dr. Jerry Owen. Even though Eagle is really just in its infancy with regard to its conceptualization, it is evident that given the experience of their leader Dr. Guy Banta and the cadre of staff members he has assembled; combined with the years of experience and expertise in their respective fields exceeds that of most companies doing business in the federal arena for more than 10 years. The mission and vision of Eagle Applied Sciences, LLC is clear, to continue to meet and exceed the expectations and requirements of the contract and continuously strive to be on the cutting edge of highend science, research and technological advancements. ETC Announces Contract to Create Jobs Environmental Tectonics Corporation held a public event in November 2009 at The National AeroSpace Training and Research Center (NASTAR Center). Joined by Pennsylvania Congressman Patrick Murphy (D-8th District) and local officials, ETC announced the award of a $40 million dollar contract from the Republic of Korea (South Korea) that will result in the creation and preservation of hundreds of local Pennsylvania jobs at ETC and its Team ETC manufacturers. The contract features the manufacture of two next-generation, motion-based flight simulation devices that will improve the health, safety, and training of pilots. The two devices will be manufactured by Team ETC and assembled their Southampton, PA, plant. ETC has been developing high-performance aeromedical training and research devices for 40 years. The public announcement event held at The NASTAR Center was attended by the news media, local businesses, university members, Team ETC members, and featured PA Congressman Patrick Murphy, Bucks County Commissioner James F. Cawley, and ETC CEO and President William F. Mitchell. —From a press release at www.etcusa.com/corp/pressreleases/NR111309.html. Florida Mayo Clinic Completes 2000th Liver Transplant Mayo Clinic recently announced that the Gary and Dianne McCalla Transplant Center at its Florida campus had completed its 2000th liver transplant. The facility began doing liver transplants in 1998 and over the last 5 years has been the highest volume liver transplant center in the Southeast. It also is among the top five in the United States. Mayo Clinic in Florida’s liver transplant program has reported some of the highest volumes, lowest median wait times, and highest survival rates in the country. According to the Scientific Registry of Transplant Recipients, the average median wait time for a liver at Mayo Clinic in Florida is 1 month, compared to a 16.1 month national average. Survival rates are 98.56 percent (1 month), 93.26 percent (one year) and 83.01 percent (three years) at Mayo Clinic in Florida versus a national average of 96.47 percent (one month), 87.68 percent (one year) and 79.45 percent (three years). Mayo Clinic in Florida has performed 3,185 organ transplants since its transplant center opened in 1998, including liver, heart, lung, kidney and pancreas transplantations as well as multiorgan procedures. —Adapted from www.mayoclinic.org/news2009-jax/5525.html. Sanofi-Aventis Launches Largest Ever Study of Anti-Malarial Drug Sanofi-Aventis and Medicines for Malaria Venture (MMV) announced recently that they have entered an agreement to launch the largest safety and efficacy study of an antimalarial drug. This field-monitoring program on ASAQ, a fixed-dose combination of artesunate and amodiaquine, started in Côte d’Ivoire in October 2009. MMV is a not-forprofit drug research and development organization dedicated to reducing the burden of malaria. ASAQ is the only fixed-dose combination of artesunate and amodiaquine prequalified by WHO in the treatment of Plasmodium falciparum uncomplicated malaria. ASAQ is the result of a partnership between Sanofi-Aventis and Drugs for Neglected Diseases initiative (DNDi) and was launched in 2007. Over a 2-year period, approximately 15,000 patients afflicted by malaria are expected to be enrolled. All patients diagnosed with uncomplicated malaria at public health clinics in selected parts of the Agboville district (approximately 100km north of Abidjan) will receive a prescription of ASAQ. Within a week, patients will be visited at home by specially trained community health workers to assess treatment tolerability and compliance. —Adapted from http://en.sanofi-aventis.com/binaries/20091119_asaq_en_tcm28-26720.pdf. Want to See Your Company’s News Printed Here? Benefits include:
For information on becoming a Corporate Member, please contact Gloria Carter at (703)739-2240, ext. 106, gcarter@asma.org; or Yvette DeBois. |
 |
 |
